Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors in the central anxious system, conolidine modulates alternate molecular targets. A Science Developments study observed that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, … Read More